A detailed history of Gimbal Financial transactions in Abb Vie Inc. stock. As of the latest transaction made, Gimbal Financial holds 2,940 shares of ABBV stock, worth $500,829. This represents 0.36% of its overall portfolio holdings.

Number of Shares
2,940
Previous 2,927 0.44%
Holding current value
$500,829
Previous $497 Million 12.13%
% of portfolio
0.36%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $2,129 - $2,591
13 Added 0.44%
2,940 $558 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $464 - $542
3 Added 0.1%
2,927 $497 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.07%
2,924 $533 Million
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $402,067 - $452,822
2,922 New
2,922 $453 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gimbal Financial Portfolio

Follow Gimbal Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gimbal Financial, based on Form 13F filings with the SEC.

News

Stay updated on Gimbal Financial with notifications on news.